Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 1/20 | 0.76 |
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.69 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.69 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.67 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.67 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.67 |
| ▸ | PRKCA | P17252 | 1/20 | 0.67 |
| ▸ | FABP3 | P05413 | 1/20 | 0.66 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.65 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15219033 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL27225786 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL40542 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL26108882 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL15209324 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL23225826 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL40543 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL18250362 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL21641458 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 | |
| SCHEMBL40858 | 1.00 | SELP (0.76) | SELPLPAR3LPAR1ENPP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECH PTE LTD (SG) | 2026-02-26 | — | — | US | claimed |
| US-12485388-B2 | Composite membrane and method of making the same | H2MO TECHNOLOGY PTE LTD (SG) | 2025-12-02 | — | — | US | claimed |
| CN-113766966-B | Composite film and method for producing same | 南洋理工大学 | 2024-08-27 | — | — | CN | claimed |
| US-20230132994-A1 | A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECHNOLOGY PTE LTD (SG) | 2023-05-04 | — | — | US | claimed |
| EP-4126313-A1 | A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | Nanyang Technological University (SG) | 2023-02-08 | — | — | EP | claimed |
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECH PTE LTD (SG) | 2026-02-26 | — | — | US | disclosed |
| EP-4687990-A1 | METHOD OF SYNTHESIS OF TARGETED LIPID NANOPARTICLE AND USES THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687992-A1 | LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL INHIBITING MOLECULE AND USE THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | disclosed |
| EP-4687991-A1 | LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL ENHANCING MOLECULE AND USE THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2026-02-11 | — | — | EP | disclosed |
| US-12485388-B2 | Composite membrane and method of making the same | H2MO TECHNOLOGY PTE LTD (SG) | 2025-12-02 | — | — | US | disclosed |
| WO-2025027116-A1 | NANOPARTICLES COMPRISING NUCLEIC ACID SEQUENCES ENCODING CYCLIC GMP-AMP SYNTHASE | INSTITUT CURIE (FR) | 2025-02-06 | — | — | WO | disclosed |
| WO-2024200826-A1 | LIPID-BASED NANOPARTICLE TARGETED AT ACTIVATED IMMUNE CELLS FOR THE EXPRESSION OF IMMUNE CELL INHIBITING MOLECULE AND USE THEREOF | OSE IMMUNOTHERAPEUTICS (FR) | 2024-10-03 | — | — | WO | disclosed |
| CN-113766966-B | Composite film and method for producing same | 南洋理工大学 | 2024-08-27 | — | — | CN | disclosed |
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-05-30 | — | — | US | disclosed |
| WO-2023081505-A1 | ADJUVANT COMPOUNDS AND FORMULATIONS | ADJUVANCE TECHNOLOGIES, INC. (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20230132994-A1 | A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | H2MO TECHNOLOGY PTE LTD (SG) | 2023-05-04 | — | — | US | disclosed |
| EP-4126313-A1 | A COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | Nanyang Technological University (SG) | 2023-02-08 | — | — | EP | disclosed |
| CN-108350425-A | Immuno-tumor mesodermal progenitor (IOMP) cells | 细胞治疗有限公司 | 2018-07-31 | — | — | CN | disclosed |
| US-20120100077-A1 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-20120100077-A1 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | SGMS1, SGMS2, LIPA | SELP 716/4885LPAR3 473/4885LPAR1 194/4885 |
| US-20120100077-A1 | MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION | ANXA2, DNM2, ANXA6 | SELP 916/4885LPAR3 174/4885LPAR1 208/4885 |
| US-20260054227-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING THE SAME | AQP1, AQP4, AQP3 | SELP 208/4885LPAR3 419/4885LPAR1 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.